Statement Of Cash Flows [Abstract]

Biofrontera AG - Filing #6537419

Concept 2022-01-01 to
2022-12-31
As at
2022-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
3,895 EUR
30,439 EUR
Cash flows from (used in) investing activities [abstract]
Cash flows from losing control of subsidiaries or other businesses, classified as investing activities
0 EUR
41,630 EUR
Cash flows from (used in) investing activities
981,000 EUR
42,259 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares
7,090 EUR
0 EUR
Repayments of borrowings, classified as financing activities
2,031 EUR
15,000 EUR
Payments of lease liabilities, classified as financing activities
453,000 EUR
624,000 EUR
Interest paid, classified as financing activities
198,000 EUR
4,861 EUR
Cash flows from (used in) financing activities
4,344 EUR
2,182 EUR
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
532,000 EUR
9,638 EUR
Cash and cash equivalents
6,376 EUR
6,908 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.